These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 24269735)

  • 1. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.
    Li CJ; Zhang QM; Li MZ; Zhang JY; Yu P; Yu DM
    Chin Med J (Engl); 2009 Nov; 122(21):2580-6. PubMed ID: 19951573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozotocin-induced diabetic cardiomyopathy in rats: ameliorative effect of PIPERINE via Bcl2, Bax/Bcl2, and caspase-3 pathways.
    Wang Y; Sun H; Zhang J; Xia Z; Chen W
    Biosci Biotechnol Biochem; 2020 Dec; 84(12):2533-2544. PubMed ID: 32892714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of β-casomorphin-7 on cardiomyopathy of streptozotocin-induced diabetic rats via inhibition of hyperglycemia and oxidative stress.
    Han DN; Zhang DH; Wang LP; Zhang YS
    Peptides; 2013 Jun; 44():120-6. PubMed ID: 23562714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
    Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
    Tang Q; Len Q; Liu Z; Wang W
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells.
    Liu JJ; Li DL; Zhou J; Sun L; Zhao M; Kong SS; Wang YH; Yu XJ; Zhou J; Zang WJ
    Apoptosis; 2011 Jan; 16(1):94-103. PubMed ID: 20963497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis.
    Kanter M; Aktas C; Erboga M
    Food Chem Toxicol; 2012 Mar; 50(3-4):719-25. PubMed ID: 22166789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of exenatide against oxidative stress-induced injury.
    Chang G; Zhang D; Yu H; Zhang P; Wang Y; Zheng A; Qin S
    Int J Mol Med; 2013 Nov; 32(5):1011-20. PubMed ID: 23982489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
    Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
    Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
    Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flos Puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice.
    Yu W; Zha W; Guo S; Cheng H; Wu J; Liu C
    PLoS One; 2014; 9(5):e98044. PubMed ID: 24865768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Gsalpha compensates for myocyte loss in diabetic cardiomyopathy.
    Malhotra A; Kang BP; Vashistha H; Yadav VS; Meggs LG
    Can J Physiol Pharmacol; 2008 Mar; 86(3):122-30. PubMed ID: 18418439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.
    Gimenes R; Gimenes C; Rosa CM; Xavier NP; Campos DHS; Fernandes AAH; Cezar MDM; Guirado GN; Pagan LU; Chaer ID; Fernandes DC; Laurindo FR; Cicogna AC; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2018 Jan; 17(1):15. PubMed ID: 29343259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.
    Wang X; Cheng Y; Xue H; Yue Y; Zhang W; Li X
    Fitoterapia; 2015 Sep; 105():16-25. PubMed ID: 26025856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.